Rezultati pretraživanja
  1. 4. velj

    Speaking at 2020, , of gives an update the company's progress with its investigational medicine, OV101 (gaboxadol) for the treatment of Angelman syndrome and Fragile X syndrome >>

  2. 4. velj

    . executives Sol Babani and Scott Schliebner talk to us about the importance of small and emerging companies who are on the leading edge of innovation in .

  3. 4. velj

    Michelle Keefe, President Commercial Solutions , spoke with CG Life Managing Partner Erik Clausen at 2020 to explore what the year has in store for . Listen here:

  4. 4. velj
  5. 3. velj

    This map tracks the coronavirus in real time

  6. 1. velj
  7. 30. sij

    Michelle Keefe, President of Commercial Solutions at explores what the year has in store for >>

  8. 29. sij

    Pacylex- Data from four different preclinical models suggest that PCLX-001 has robust efficacy in leukemia and lymphoma

  9. 29. sij

    Pacylex- Data from four different preclinical models suggest that PCLX-001 has robust efficacy in leukemia and lymphoma

  10. 29. sij
  11. 29. sij

    The virtual liver will be the biotech breakthrough of the 2020s. Much like a real liver performing vital life functions but 100% scalable in the cloud.

  12. 29. sij

    Another interview is up! Hear Michelle Keefe, President of Commercial Solutions , explore what the drug industry should do to tell patient stories about positive therapeutic impact. Plus, her 2020 outlook & more!

  13. 28. sij

    Speaking at 2020, , of gives an update the company's progress with its investigational medicine, OV101 (gaboxadol) for the treatment of Angelman syndrome and Fragile X syndrome >>

  14. 28. sij

    Did you miss and ? Discover what leaders and experts in both biotech and finance had to say during the busiest week in healthcare >>

  15. 27. sij

    Check out 's first interview with Dr. Jeremy Levin, Chairman & CEO . Dr. Levin discusses 2020 biotech investment, Ovid's progress with its investigational medicine for Angelman & Fragile X syndromes, & more!

  16. 27. sij

    Discover what leaders and experts in both biotech and finance had to say during the busiest week in healthcare while attending and >>

  17. 26. sij

    Omnix Medical's CSO, Dr. Niv Bachnoff gave an outstanding presentation to a full house at during which was very well-received!

    Prikaži ovu nit
  18. 26. sij
  19. 23. sij
  20. 23. sij

    2020 event drew together 3,800 attendees, 400 presenting companies, and over 1,000 investors. We hope that you found it to be a successful and valuable experience, and hope to see you all next year!

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.